Do you want to further your understanding of overfitting, or are you interested to learn how we avoid overfitting when developing predictive machine learning models for clinical research? Browse our tech note, which includes a step-by-step, published example of how we developed a model that was able to successfully support the evaluation of kidney cancer tumor upstaging in individual patients.
POSTER SPOTLIGHT: The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay